Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

Total article views   HTML views PDF downloads Totals
5,414 Dovepress* 4,927+ 622 5,549
PubMed Central* 487 146 633
Totals 5,414 768 6,182
*Since 22 April 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar